Promedior, Inc. (Promedior)

Oncology Corporate Profile

HQ Location

101 Hartwell Avenue
Lexington, MA 02421

Company Description

Promedior is a clinical-stage biotechnology company pioneering the development of targeted therapeutics to treat fibrotic diseases. Fibrosis is a process that occurs in many diseases, when normal healthy tissue is replaced with scar tissue, compromising normal function and leading ultimately to organ failure. Promedior's proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that acts through a unique anti-fibrotic immunotherapy mechanism to activate a regulatory switch upstream in the fibrosis cascade.

Website: http://www.promedior.com/

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
PRM-151rhPTX-2MyelofibrosisII

View additional information on product candidates here »

Pipeline image

Source


http://www.promedior.com/

Recent News Headlines

There are no news items to display